A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells

Abel Soto-Gamez(University Medical Center Groningen), Ykelien L. Boersma(University of Zurich)
Cancers
February 10, 2020
Cited by 15


Related Papers